Artículos de revistas sobre el tema "GLS1"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "GLS1".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Vidula, Neelima, Christina Yau y Hope S. Rugo. "Glutaminase (GLS) expression in primary breast cancer (BC): Correlations with clinical and tumor characteristics." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 558. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.558.
Texto completoRojas, Livisu Pajares y Claudia Machicado Rivero. "Abstract 883: Glutaminases expression and viral infection as potential prognostic factors in cervical, head and neck and liver cancers". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 883. http://dx.doi.org/10.1158/1538-7445.am2023-883.
Texto completoBright, Scott J., Rishab Kolachina, Mariam Ben Kacem, Mandira Manandhar, Philip Jones, Timothy A. Yap, Steven H. Lin y Gabriel O. Sawakuchi. "Abstract B030: Modulating mitochondria metabolism to radiosensitize KEAP1 mutated non-small cell lung cancer". Cancer Research 84, n.º 1_Supplement (9 de enero de 2024): B030. http://dx.doi.org/10.1158/1538-7445.dnarepair24-b030.
Texto completoXiao, Yangbo, Rong Huang, Shenping Cao, Dafang Zhao, Zhuangwen Mao, Chuchu Xiao, Zhehua Xu et al. "Molecular Characterization and Dietary Regulation of Glutaminase 1 (gls1) in Triploid Crucian Carp (Carassius auratus)". Fishes 7, n.º 6 (7 de diciembre de 2022): 377. http://dx.doi.org/10.3390/fishes7060377.
Texto completoMyint, Zin W., Ramon C. Sun, Patrick J. Hensley, Andrew C. James, Peng Wang, Stephen E. Strup, Robert J. McDonald, Donglin Yan, William H. St. Clair y Derek B. Allison. "Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters". Cancers 13, n.º 9 (29 de abril de 2021): 2157. http://dx.doi.org/10.3390/cancers13092157.
Texto completoYang, Jianqiang, Fanghui Chen, Fan Yang y Yong Teng. "Abstract 3061: A positive feedback loop between GLS1 and c-Myc drives tumor aggressiveness". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 3061. http://dx.doi.org/10.1158/1538-7445.am2024-3061.
Texto completoAhmed, Shanzay, Peter John, Rehan Zafar Paracha, Attya Bhatti y Monica Guma. "Docking and Molecular Dynamics Study to Identify Novel Phytobiologics from Dracaena trifasciata against Metabolic Reprogramming in Rheumatoid Arthritis". Life 12, n.º 8 (29 de julio de 2022): 1148. http://dx.doi.org/10.3390/life12081148.
Texto completoKono, Michihito, Nobuya Yoshida, Kayaho Maeda y George C. Tsokos. "Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells". Proceedings of the National Academy of Sciences 115, n.º 10 (20 de febrero de 2018): 2478–83. http://dx.doi.org/10.1073/pnas.1714717115.
Texto completoBeręsewicz-Haller, Małgorzata, Olga Krupska, Paweł Bochomulski, Danuta Dudzik, Anita Chęcińska, Wojciech Hilgier, Coral Barbas, Krzysztof Zablocki y Barbara Zablocka. "Mitochondrial Metabolism behind Region-Specific Resistance to Ischemia-Reperfusion Injury in Gerbil Hippocampus. Role of PKCβII and Phosphate-Activated Glutaminase". International Journal of Molecular Sciences 22, n.º 16 (7 de agosto de 2021): 8504. http://dx.doi.org/10.3390/ijms22168504.
Texto completoMyint, Zin, Patrick J. Hensley, Andrew Callaway James, Peng Wang, Stephen Strup, Donglin Yan, William H. St Clair, Robert S. DiPaola y Derek B. Allison. "Immunohistochemical evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters." Journal of Clinical Oncology 39, n.º 6_suppl (20 de febrero de 2021): 251. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.251.
Texto completoSyarifin, Andi N. K., Sri W. A. Jusman y Mohamad Sadikin. "Gene expression and enzyme activities of carbonic anhydrase and glutaminase in rat kidneys induced by chronic systemic hypoxia". Medical Journal of Indonesia 24, n.º 3 (9 de noviembre de 2015): 139–45. http://dx.doi.org/10.13181/mji.v24i3.1190.
Texto completoHage, Maha El, Justine Masson, Agnès Conjard-Duplany, Bernard Ferrier, Gabriel Baverel y Guy Martin. "Brain Slices from Glutaminase-Deficient Mice Metabolize Less Glutamine: A Cellular Metabolomic Study with Carbon 13 NMR". Journal of Cerebral Blood Flow & Metabolism 32, n.º 5 (29 de febrero de 2012): 816–24. http://dx.doi.org/10.1038/jcbfm.2012.22.
Texto completoAkar, Hamurcu y Donmez-Altuntas. "The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells". Proceedings 40, n.º 1 (26 de diciembre de 2019): 25. http://dx.doi.org/10.3390/proceedings2019040025.
Texto completoFu, Jiayao, Yiping Pu, Baoli Wang, Hui Li, Xiujuan Yang, Lisong Xie, Huan Shi et al. "Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren’s Syndrome". Journal of Immunology Research 2022 (15 de febrero de 2022): 1–13. http://dx.doi.org/10.1155/2022/3210200.
Texto completoCoen, Chad, Jizhi Yan, Caner Saygin, Nicole Arellano, Mirielle Nauman, Katarzyna Zawieracz, Daniele Vanni et al. "Glutamine Metabolism Is Altered in Myeloproliferative Neoplasms and Represents a Potential Novel Therapeutic Target". Blood 142, Supplement 1 (28 de noviembre de 2023): 6350. http://dx.doi.org/10.1182/blood-2023-189731.
Texto completoYoshikawa, Sachiko, Manabu Nagao, Ryuji Toh, Masakazu Shinohara, Takuya Iino, Yasuhiro Irino, Makoto Nishimori et al. "Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling". American Journal of Physiology-Heart and Circulatory Physiology 322, n.º 5 (1 de mayo de 2022): H749—H761. http://dx.doi.org/10.1152/ajpheart.00692.2021.
Texto completoFeng, Yifan, Xi Yang, Jinhai Huang, Minqian Shen, Liyang Wang, Xiuping Chen, Yuanzhi Yuan, Chunqiong Dong, Xiaoping Ma y Fei Yuan. "Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages". Oxidative Medicine and Cellular Longevity 2022 (19 de marzo de 2022): 1–19. http://dx.doi.org/10.1155/2022/1106313.
Texto completoXu, Lingfan, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang, Juan Liu et al. "A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer". Proceedings of the National Academy of Sciences 118, n.º 13 (22 de marzo de 2021): e2012748118. http://dx.doi.org/10.1073/pnas.2012748118.
Texto completoShibuya, Aya, Neil Margulis, Romain Christiano, Tobias C. Walther y Charles Barlowe. "The Erv41–Erv46 complex serves as a retrograde receptor to retrieve escaped ER proteins". Journal of Cell Biology 208, n.º 2 (12 de enero de 2015): 197–209. http://dx.doi.org/10.1083/jcb.201408024.
Texto completoXiong, Jian, Thi Thu Trang Luu, Kartik Venkatachalam, Guangwei Du y Michael X. Zhu. "Glutamine Produces Ammonium to Tune Lysosomal pH and Regulate Lysosomal Function". Cells 12, n.º 1 (24 de diciembre de 2022): 80. http://dx.doi.org/10.3390/cells12010080.
Texto completoAbdel-Magid, Ahmed F. "Glutaminase GLS1 Inhibitors as Potential Cancer Treatment". ACS Medicinal Chemistry Letters 7, n.º 3 (febrero de 2016): 207–8. http://dx.doi.org/10.1021/acsmedchemlett.6b00016.
Texto completoGuba, B. S. y V. V. Lyubimov. "Relationship between the effective saturation energy and the amplification diagram of GLS1 and GLS2 neodymium glasses". Soviet Journal of Quantum Electronics 20, n.º 9 (30 de septiembre de 1990): 1075–78. http://dx.doi.org/10.1070/qe1990v020n09abeh007407.
Texto completoLee, You Won, Hun Mi Choi, Seung Yeon Oh, Eun Ji Lee, Kyoung-Ho Pyo, Jae Hwan Kim, Youngseon Byeon et al. "Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): LB544. http://dx.doi.org/10.1158/1538-7445.am2022-lb544.
Texto completoJovanovic, Katarina K., Léa Fléchon, Mairead Reidy, Jihye Park, Xavier Leleu, Irene M. Ghobrial, Thierry Facon, Bruno Quesnel y Salomon Manier. "MYC Overexpressing Multiple Myeloma Are Dependent on GLS1". Blood 134, Supplement_1 (13 de noviembre de 2019): 853. http://dx.doi.org/10.1182/blood-2019-128484.
Texto completoRojo-Báez, Indira, Raymundo S. García-Estrada, Josefina León-Félix, J. Adriana Sañudo-Barajas y Raúl Allende-Molar. "EXPRESIÓN GÉNICA DURANTE EL PROCESO DE INFECCIÓN DE Colletotrichum truncatum (SCHWEIN.) EN PAPAYA MARADOL". Revista Fitotecnia Mexicana 44, n.º 2 (28 de junio de 2021): 221. http://dx.doi.org/10.35196/rfm.2021.2.221.
Texto completoSponagel, Jasmin, Shanshan Zhang, Prakash Chinnaiyan, Joshua Rubin y Joseph Ippolito. "TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology 22, Supplement_3 (1 de diciembre de 2020): iii467. http://dx.doi.org/10.1093/neuonc/noaa222.830.
Texto completoLiu, Haixin, Haolun Tian, Pengcheng Hao, Huimin Du, Kun Wang, Yudong Qiu, Xiangrui Yin et al. "PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism". PLOS Pathogens 20, n.º 6 (21 de junio de 2024): e1012305. http://dx.doi.org/10.1371/journal.ppat.1012305.
Texto completoKim, Sewha, Do Hee Kim, Woo-Hee Jung y Ja Seung Koo. "Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer". Endocrine-Related Cancer 20, n.º 3 (18 de marzo de 2013): 339–48. http://dx.doi.org/10.1530/erc-12-0398.
Texto completoSponagel, Jasmin, Shanshan Zhang, Cheryl Frankfater, Jill Jones, Din Selmanovic, Prakash Chinnaiyan, Joshua B. Rubin y Joseph E. Ippolito. "FSMP-19. SEX DIFFERENCES IN REDOX REGULATION UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology Advances 3, Supplement_1 (1 de marzo de 2021): i19—i20. http://dx.doi.org/10.1093/noajnl/vdab024.082.
Texto completoChattopadhyaya, Sikta, Raghu Nagalingam, Pavit Narhan y Michael Czubryt. "Regulation of GLS1 Expression by Scleraxis in Cardiac Fibroblasts". FASEB Journal 34, S1 (abril de 2020): 1. http://dx.doi.org/10.1096/fasebj.2020.34.s1.05913.
Texto completoXia, Xichun, Guangchao Cao, Guodong Sun, Leqing Zhu, Yixia Tian, Yueqi Song, Chengbin Guo et al. "GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis". Journal of Clinical Investigation 130, n.º 10 (24 de agosto de 2020): 5180–96. http://dx.doi.org/10.1172/jci129269.
Texto completoChen, Weihua, Weifeng Wang, Jun Zhang, Guoqiang Liao, Jie Bai, Bo Yang, Mingyue Tan y Hua Gong. "Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression". Journal of Oncology 2022 (11 de enero de 2022): 1–9. http://dx.doi.org/10.1155/2022/7985468.
Texto completoKrishna, Gayathri, Vinod Soman Pillai y Mohanan Valiya Veettil. "Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells". Viruses 12, n.º 8 (27 de julio de 2020): 811. http://dx.doi.org/10.3390/v12080811.
Texto completoNaka, I., J. Saegusa, K. Uto, Y. Yamamoto, Y. Ichise, H. Yamada, K. Akashi et al. "SAT0011 COMBINED INHIBITION OF AUTOPHAGY AND GLUTAMINE METABOLISM SUPPRESSES CELL GROWTH OF RA SYNOVIOCYTES AND AMELIORATES ARTHRITIS IN SKG MICE". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 935.2–936. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1661.
Texto completoPoonaki, Elham, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak y Ulf Dietrich Kahlert. "CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells". International Journal of Molecular Sciences 23, n.º 10 (13 de mayo de 2022): 5479. http://dx.doi.org/10.3390/ijms23105479.
Texto completoXu, Kangdi, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou y Shusen Zheng. "SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis". Cells 12, n.º 1 (21 de diciembre de 2022): 25. http://dx.doi.org/10.3390/cells12010025.
Texto completoLang, Liwei, Fang Wang, Chloe Shay, Yonggang Ke, Nabil Saba y Yong Teng. "Abstract 3026: Inhibition of glutaminolysis overcomes metabolic adaptation to devimistat treatment". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3026. http://dx.doi.org/10.1158/1538-7445.am2022-3026.
Texto completoOzcan, Selahattin C., Aydan Mutlu, Tugba H. Altunok, Yunus Gurpinar, Aybike Sarioglu, Sabire Guler, Robertino J. Muchut et al. "Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells". Biochemical and Biophysical Research Communications 571 (septiembre de 2021): 118–24. http://dx.doi.org/10.1016/j.bbrc.2021.07.070.
Texto completoXi, Jianbo, Yaocheng Sun, Meiting Zhang, Zhenzhong Fa, Yanya Wan, Zhenyu Min, Hong Xu, Chengkai Xu y Jianjun Tang. "GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway". Experimental Cell Research 381, n.º 1 (agosto de 2019): 1–9. http://dx.doi.org/10.1016/j.yexcr.2019.04.005.
Texto completoJo, Michiko, Keiichi Koizumi, Mizuho Suzuki, Daisuke Kanayama, Yurie Watanabe, Hiroaki Gouda, Hisashi Mori et al. "Design, synthesis, structure–activity relationship studies, and evaluation of novel GLS1 inhibitors". Bioorganic & Medicinal Chemistry Letters 87 (mayo de 2023): 129266. http://dx.doi.org/10.1016/j.bmcl.2023.129266.
Texto completoOkada, Takuya, Kaho Yamabe, Michiko Jo, Yuko Sakajiri, Tomokazu Shibata, Ryusuke Sawada, Yoshihiro Yamanishi et al. "Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity". Bioorganic & Medicinal Chemistry Letters 93 (septiembre de 2023): 129438. http://dx.doi.org/10.1016/j.bmcl.2023.129438.
Texto completoLam, Elaine T., Lih-Jen Su, Maren Salzmann-Sullivan, Steven K. Nordeen y Thomas W. Flaig. "Preclinical evaluation of teleglenastat (CB-839) in prostate cancer." Journal of Clinical Oncology 41, n.º 6_suppl (20 de febrero de 2023): 378. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.378.
Texto completoLi, Lingzhi, Changying Jiang, Lucy Jayne Navsaria, Yang Liu, Angela Leeming, Michael Wang y Yixin Yao. "Targeting Glutamine Metabolism Overcomes Resistance to Targeted Therapies in Refractory Mantle Cell Lymphoma". Blood 136, Supplement 1 (5 de noviembre de 2020): 25–26. http://dx.doi.org/10.1182/blood-2020-140736.
Texto completoMoncada, Salvador, E. Annie Higgs y Sergio L. Colombo. "Fulfilling the metabolic requirements for cell proliferation". Biochemical Journal 446, n.º 1 (27 de julio de 2012): 1–7. http://dx.doi.org/10.1042/bj20120427.
Texto completoMatre, Polina, Ismael Samudio, Rodrigo Jacamo, Ying Wang, Jing Wang, R. Eric Davis, Xiaohua Su et al. "Unraveling The Molecular and Metabolic Basis For Glutamine Addiction In Leukemias". Blood 122, n.º 21 (15 de noviembre de 2013): 606. http://dx.doi.org/10.1182/blood.v122.21.606.606.
Texto completoWu, Shuai, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu et al. "Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma". Nature Cancer 2, n.º 2 (11 de enero de 2021): 189–200. http://dx.doi.org/10.1038/s43018-020-00160-x.
Texto completoCai, Wei-Feng, Cixiong Zhang, Yu-Qing Wu, Gui Zhuang, Zhiyun Ye, Chen-Song Zhang y Sheng-Cai Lin. "Glutaminase GLS1 senses glutamine availability in a non-enzymatic manner triggering mitochondrial fusion". Cell Research 28, n.º 8 (22 de junio de 2018): 865–67. http://dx.doi.org/10.1038/s41422-018-0057-z.
Texto completoGao, Chuan-Cheng, Qin-Qin Xu, Feng-Jun Xiao, Hua Wang, Chu-Tse Wu y Li-Sheng Wang. "NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing". Biochemical and Biophysical Research Communications 526, n.º 2 (mayo de 2020): 431–38. http://dx.doi.org/10.1016/j.bbrc.2020.03.089.
Texto completoHenry, Christophe, Dimitri Gorge-Bernat, Pascal Pannier, Isabelle Meaux, Jane Cheng, Fangxian Sun, Olivier Pasquier et al. "Abstract 6033: RA123, a new GLS1 allosteric inhibitor demonstrates in vitro and in vivo activity in multiple myeloma models". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 6033. http://dx.doi.org/10.1158/1538-7445.am2023-6033.
Texto completoSponagel, Jasmin, Shanshan Zhang, Jill Jones, Prakash Chinnaiyan, Joshua Rubin y Joseph Ippolito. "TAMI-37. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii221. http://dx.doi.org/10.1093/neuonc/noaa215.925.
Texto completo